Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adjuvant Immunotherapy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04605146
What this trial is testing

Impact of Telemonitoring for the Management of Side Effects in Patients with Melanoma, Lung or Renal Cancer, Treated with Immunotherapy Combination of Nivolumab and Ipilimumab or Adjuvant Nivolumab Monotherapy

Who this might be right for
MelanomaLung CancerRenal Cancer
Hospices Civils de Lyon 100
Large-scale testing (Phase 3)Study completedNCT04209114
What this trial is testing

Nivolumab Plus Bempegaldesleukin (Bempeg/NKTR-214) vs Nivolumab Alone vs Standard of Care in Participants With Bladder Cancer That May Have Invaded The Muscle Wall of the Bladder and Who Cannot Get Cisplatin, A Type of Medicine Given To Treat Bladder Cancer

Who this might be right for
Bladder CancerBladder TumorMuscle-Invasive Bladder Cancer
Bristol-Myers Squibb 114
Testing effectiveness (Phase 2)Looking for participantsNCT07227636
What this trial is testing

Botensilimab and Balstilimab for Colorectal Cancer With ctDNA+ After Surgery and Chemotherapy

Who this might be right for
Colorectal CancerRectal Cancer
Memorial Sloan Kettering Cancer Center 284
Testing effectiveness (Phase 2)Looking for participantsNCT07679399
What this trial is testing

A Phase II Study of Adjuvant Durvalumab Combined With GEMOX/GC Chemotherapy Followed by Lenvatinib Versus Capecitabine in Biliary Tract Cancer.

Who this might be right for
Biliary Tract Neoplasms Immunotherapy
Peking Union Medical College Hospital 222
Large-scale testing (Phase 3)Study completedNCT02388906
What this trial is testing

Efficacy Study of Nivolumab Compared to Ipilimumab in Prevention of Recurrence of Melanoma After Complete Resection of Stage IIIb/c or Stage IV Melanoma

Who this might be right for
Melanoma
Bristol-Myers Squibb 906
Testing effectiveness (Phase 2)Looking for participantsNCT06727617
What this trial is testing

Serplulimab With Chemoradiotherapy for Postoperative Cervical Cancer With Risk Factors

Who this might be right for
Cervical Cancers
Tianjin Medical University Cancer Institute and Hospital 134
Testing effectiveness (Phase 2)Study completedNCT01309230
What this trial is testing

A Trial of FANG™ Vaccine for Participants With Ovarian Cancer

Who this might be right for
Ovarian Cancer
Gradalis, Inc. 39
Testing effectiveness (Phase 2)Looking for participantsNCT04671667
What this trial is testing

Testing What Happens When an Immunotherapy Drug (Pembrolizumab) is Given by Itself Compared to the Usual Treatment of Chemotherapy With Radiation After Surgery for Recurrent Head and Neck Squamous Cell Carcinoma

Who this might be right for
Recurrent Head and Neck Squamous Cell CarcinomaRecurrent Hypopharyngeal Squamous Cell CarcinomaRecurrent Laryngeal Squamous Cell Carcinoma+2 more
National Cancer Institute (NCI)
Testing effectiveness (Phase 2)Active Not RecruitingNCT03897881
What this trial is testing

An Efficacy Study of Adjuvant Treatment With the Personalized Cancer Vaccine mRNA-4157 and Pembrolizumab in Participants With High-Risk Melanoma (KEYNOTE-942)

Who this might be right for
Melanoma
ModernaTX, Inc. 267
Testing effectiveness (Phase 2)Active Not RecruitingNCT03383094
What this trial is testing

Chemoradiation vs Immunotherapy and Radiation for Head and Neck Cancer

Who this might be right for
Head and Neck Squamous Cell CarcinomaCancerCancer of Head and Neck+12 more
Loren Mell, MD 126
Testing effectiveness (Phase 2)UnknownNCT04969029
What this trial is testing

Immunotherapy Versus Chemotherapy as Adjuvant Therapy for Colon Cancer With MSI-H or POLE/ POLD1 Mutations

Who this might be right for
ImmunotherapyAdjuvant TherapyColon Cancer+1 more
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)Looking for participantsNCT07400302
What this trial is testing

Sintilimab Combined With Chemotherapy for Adjuvant Treatment of Mucosal Melanoma After Surgery

Who this might be right for
Mucosal MelanomaPD-L1 Positive
The First Hospital of Jilin University 220
Testing effectiveness (Phase 2)Looking for participantsNCT04198766
What this trial is testing

Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+5 more
Inhibrx Biosciences, Inc 340
Large-scale testing (Phase 3)Not Yet RecruitingNCT06089382
What this trial is testing

Evaluate Sintilimab Plus Lenvatinib as Adjuvant Therapy in Hepatocellular Carcinoma With Portal Vein Tumor Thrombosis (PVTT) After Surgical Resection

Who this might be right for
Hepatocellular Carcinoma
Tongji Hospital 104
Testing effectiveness (Phase 2)Ended earlyNCT00415857
What this trial is testing

Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and PEG-INTRON(R)

Who this might be right for
Leukemia
M.D. Anderson Cancer Center 5
Large-scale testing (Phase 3)Looking for participantsNCT06488482
What this trial is testing

Assessment of Short Immunotherapy After Radical Surgery of High-risk Malignant Melanoma

Who this might be right for
High-risk Melanoma
Uppsala University 1,792
Testing effectiveness (Phase 2)Study completedNCT01473810
What this trial is testing

Intranasal Modified Vacc-4x Gag Peptides With Endocine as Adjuvant

Who this might be right for
HIV Infection
Oslo University Hospital 24
Not applicableActive Not RecruitingNCT07256002
What this trial is testing

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

Who this might be right for
Lung Cancer (NSCLC)
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 10,000
Testing effectiveness (Phase 2)Study completedNCT00143845
What this trial is testing

Study of Low-Intensity Conditioning for Allogeneic Stem Cell Transplant

Who this might be right for
Multiple MyelomaLymphocytic Leukemia, ChronicLymphoma, Low-Grade
University of Michigan Rogel Cancer Center 54
Large-scale testing (Phase 3)Looking for participantsNCT05232916
What this trial is testing

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

Who this might be right for
Breast Cancer
Greenwich LifeSciences, Inc. 2,250
Next Page
188